Tobramycin

Product manufactured by Sandoz Inc

Application Nr Approved Date Route Status External Links
NDA050753 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Tobramycin Inhalation Solution Is Indicated For The Management Of Cystic Fibrosis Patients With P. Aeruginosa . Safety And Efficacy Have Not Been Demonstrated In Patients Under The Age Of 6 Years, Patients With Forced Expiratory Volume In 1 Second (Fev 1 ) <25% Or >75% Predicted, Or Patients Colonized With Burkholderia Cepacia (See Clinical Studies ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tobramycin TOBRAMYCIN ZINC8214692

Comments